NDC 66993-416-81 - Montelukast Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66993-416
- Requested NDC
- 66993-416-81
- Package NDCs from labels
- 66993-416-81, 66993-416-30
- Manufacturer
- Prasco Laboratories | Merck Sharp & Dohme Corp.
- Effective date
- 2020-04-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Montelukast Sodium - Prasco Laboratories | Merck Sharp & Dohme Corp. | Prasco Laboratories | Merck Sharp & Dohme Corp. | 2020-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66993-416-30 | EA - Each | 66993-416 | 84d657ba-11f6-4e70-a4f1-28fdc5683f01 | 1 | 2013-09-04 |
| 66993-416-81 | EA - Each | 66993-416 | 153cea6c-9237-42b6-b2d4-3a821511d8c4 | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| montelukast sodium | ACTIVE INGREDIENT | U1O3J18SFL | MONTELUKAST SODIUM GRANULE [PRASCO LABORATORIES] | 5 | |
| montelukast | ACTIVE MOIETY | MHM278SD3E | MONTELUKAST SODIUM GRANULE [PRASCO LABORATORIES] | 5 | |
| hydroxypropyl cellulose (type h) | INACTIVE INGREDIENT | RFW2ET671P | MONTELUKAST SODIUM GRANULE [PRASCO LABORATORIES] | 5 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | MONTELUKAST SODIUM GRANULE [PRASCO LABORATORIES] | 5 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | MONTELUKAST SODIUM GRANULE [PRASCO LABORATORIES] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Montelukast | MONTELUKAST | Coupler LLC | 583a9499-97f0-2ebf-e063-6394a90a35af | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Torrent Pharmaceuticals Limited | da038cf6-cfad-43a4-ab8e-d81d028d6087 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals Inc. | 1eeb3123-9e93-4681-8096-800a7c7acf8a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Preferred Pharmaceuticals, Inc. | 94642db1-5c75-44c4-92b4-8385b486df82 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals Inc. | 64a3b181-e8d8-4caf-9f1b-e0063d0bd94a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Rising Pharma Holdings, Inc. | 49669ac0-0bb5-4576-bed5-9e85e0d76a44 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast | MONTELUKAST | REMEDYREPACK INC. | ecaa9b4b-5941-4af5-930c-35e9f3b2b4ba | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | AvPAK | d7870c45-5a8b-8369-e053-2a95a90ae1f3 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | Redpharm Drug | 2fbdf1be-a37f-879b-e063-6394a90aa20d | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Chartwell RX, LLC | 5cb4298c-10b1-4d6f-95ad-4aad72daf249 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST SODIUM | AvKARE | ed2caffa-a75c-1c27-ae30-2d8280eaea7d | 2025-12-16 | Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST | MONTELUKAST SODIUM | A-S Medication Solutions | da9821f1-536a-416b-9594-210bde0cefaf | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast Sodium | MONTELUKAST SODIUM | AvPAK | 2f90a573-27fd-cc16-f3d1-8c4d630224a0 | 2025-10-29 | Warnings, Adverse reactions | U1O3J18SFL |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast Sodium | MONTELUKAST SODIUM | PD-Rx Pharmaceuticals, Inc. | c9ec1996-6a54-4622-b8a6-57dea49f6b35 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.